Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality
- PMID: 36164922
- PMCID: PMC9935052
- DOI: 10.1093/europace/euac170
Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality
Abstract
Aims: Same-day discharge is increasingly common after catheter ablation for atrial fibrillation (AF). However, the impact of same-day discharge on healthcare utilization after ablation and whether this differs by ablation modality remains uncertain. We examined the safety, efficacy, and subsequent healthcare utilization of a same-day discharge protocol for AF ablation, including radiofrequency (RF) and cryoballoon ablation, in a contemporary cohort.
Methods and results: All consecutive patients for whom full healthcare utilization data were available at two centres and who underwent AF ablation from 2018 to 2019 were included. Same-day discharge was the default strategy for all patients. The efficacy and safety outcomes were proportions of same-day discharge and readmission/emergency room (ER) visits, and post-discharge complications, respectively. Of the 421 patients who underwent AF ablation (mean 63.3 ± 10.2 years, 33% female), 90.5% (381/421) achieved same-day discharge with no difference between RF and cryoballoon ablation (89.8 vs. 95.1%, adjusted P = 0.327). Readmission ≤30 days occurred in 4.8%, with ER visits ≤30 days seen in 26.1% with no difference between ablation modalities (P = 0.634). Patients admitted overnight were more likely to present to the ER (40.0 vs. 24.7% with same-day discharge, P = 0.036). The overall post-discharge complication rate was low at 4/421 (1.0%), with no difference between ablation modality (P = 0.324) and admission/same-day discharge (P = 0.485).
Conclusion: Same-day discharge can be achieved in a majority of patients undergoing RF or cryoballoon ablation for AF. Healthcare utilization, particularly ER visits, remains high after AF ablation, regardless of ablation modality or same-day discharge.
Keywords: Atrial fibrillation; Catheter ablation; Cryotherapy; Outcomes; Radiofrequency.
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: M.W.D. reports honoraria and research funding from Biosense Webster, and honoraria from Medtronic, Abbott, and Boston Scientific. J.G.A. reports research funding and honoraria from Medtronic.
Figures



References
-
- Andrade JG, Wazni OM, Kuniss M, Hawkins NM, Deyell MW, Chierchia GBet al. . Cryoballoon ablation as initial treatment for atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol 2021;78:914–30. - PubMed
-
- Tripathi B, Arora S, Kumar V, Abdelrahman M, Lahewala S, Dave Met al. . Temporal trends of in-hospital complications associated with catheter ablation of atrial fibrillation in the United States: an update from Nationwide Inpatient Sample database (2011–2014). J Cardiovasc Electrophysiol 2018;29:715–24. - PubMed
-
- Noseworthy PA, Kapa S, Haas LR, Van Houten H, Deshmuk AJ, Mulpuru SKet al. . Trends and predictors of readmission after catheter ablation for atrial fibrillation, 2009–2013. Am Heart J 2015;170:483–9. - PubMed
-
- Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle Let al. . Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring: a randomized clinical trial. Circulation 2019;140:1779–88. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical